Skip to main content

MoneyWorks4Me

The sales declined to Rs. 390.60 millions for the March 2025 quarter as compared to Rs. 413.98 millions during the corresponding quarter last year.Net profit declined -9.89% to Rs. 13.12 millions from Rs. 14.56 millions.The company reported a good operating profit of 41.38 millions compared to 34.03 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 390.60 413.98 -5.65 1458.57 1524.66 -4.33 1458.57 1524.66 -4.33
Other Income 10.25 5.15 99.03 27.42 35.22 -22.15 27.42 35.22 -22.15
PBIDT 41.38 34.03 21.60 139.19 146.34 -4.89 139.19 146.34 -4.89
Interest 8.22 6.76 21.60 27.31 22.90 19.26 27.31 22.90 19.26
PBDT 15.27 27.27 -44.00 90.42 123.44 -26.75 90.42 123.44 -26.75
Depreciation 2.15 12.71 -83.08 48.90 49.95 -2.10 48.90 49.95 -2.10
PBT 13.12 14.56 -9.89 41.52 73.49 -43.50 41.52 73.49 -43.50
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 13.12 14.56 -9.89 41.52 73.49 -43.50 41.52 73.49 -43.50
Equity 236.56 236.56 0.00 236.56 236.56 0.00 236.56 236.56 0.00
PBIDTM(%) 10.59 8.22 28.88 9.54 9.60 -0.58 9.54 9.60 -0.58
Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1371.20
Cipla 1409.00
Lupin 1990.00
Zydus Lifesciences 1195.00
View more..